Disc Medicine

Rare Disease Therapeutics
9open roles
$241kmedian advertised pay
50+people
4cities with offices

Overview

Committed to turning scientific discoveries into effective medicines that will disrupt the current standard of care, alleviate suffering, and have a meaningful impact on the lives of patients and their families.

Jobs

Hybrid · 12+ years exp · Master's Degree · United States
Smartsheet
Apply
$186k – $228k per year · Remote (United States) · 3+ years exp · PhD
Apply
$186k – $228k per year · Remote (United States) · 3+ years exp · PhD
Apply
$186k – $228k per year · Remote (United States) · 3+ years exp · PhD
Apply
$293k – $358k per year · Hybrid · 15+ years exp · United States
Apply
$174k – $212k per year · Hybrid · 10+ years exp · United States
Apply
$187k – $228k per year · Hybrid · 8+ years exp · PhD · United States
GCP
Life Sciences
Flow Cytometry
Mass Spectrometry
GLP
Apply
$247k – $297k per year · Remote (United States) · 10+ years exp · PhD · United States
Apply
$261k – $319k per year · Hybrid · 10+ years exp · United States
GLP
Apply
All 9 jobs at Disc Medicine salaries, cities, levels and how long each has been open

Salary insights

Compensation ranges based on this company's open jobs
Median
$241k
Typical range
$118k – $358k
Open positions
16
16 Jobs
Middle 25%
Senior 25%
Architect 50%
Level Jobs Median Typical range
Middle 4 $228k $118k – $228k
Senior 4 $319k $156k – $319k
Architect 8 $253k $212k – $358k
Highest paying role Executive Director, Commercial Planning $358k
Normalized to USD per year
All salaries at Disc Medicine By role, level and city, against the market · 16 jobs with pay

Visa sponsorship

United StatesUS 0
0
H-1B filings in 12 months
17
Open roles in United States
In the register as Disc Medicine, Inc., Watertown, MA
Other sponsors in the same field
Vertex Pharmaceuticals 174 filingsSanofi 62 filingsAlnylam 36 filingsNeurocrine Biosciences 18 filings
See 17 open roles Alert me
US Department of Labor · latest filing Apr 9, 2025 · Visa details by country

Growth

Hiring Momentum
52/100
Stable
Open positions
17
6 opened / 1 closed in 30 days
Median time-to-fill
51 days
faster than 26% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
33% ▼
Early Careers
21% ▲
Finance
13% ▼
Marketing
8%
Science & Research
8% ▼
Administrative
4% ▲
Actively hiring for Early Careers (+3 in 30 days)
Activity Timeline
Added Mass Spectrometry to stack Oct 2026
Added GLP to stack Oct 2026
Added Flow Cytometry to stack Oct 2026
Added Good Clinical Practice to stack Oct 2026
Added DNS to stack Sep 2026
Added DLP to stack Sep 2026
Added Microsoft Office to stack Sep 2026
Added GCP to stack Sep 2026

Tech stack

Technologies named in job postings at Disc Medicine over the last 12 months, by layer, with the share of postings for each.
Technologies in use
12
Postings analysed
10
Stack modernity
60/100
Cloud & platforms
GCP40%
Azure10%
Cloudflare10%
DLP10%
Sign in to see how your skills match this stack Sign In
Full Disc Medicine tech stack 12 technologies · by team · pay by technology · changes · similar stacks

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors3
Atlas VentureVia a fund
55 portfolio companies: Show + Tell, LifeSciVC, Vima Therapeutics and 52 more
Foresite CapitalVia a fund
131 portfolio companies: Veracyte, UpDoc, Zura Bio and 128 more
OrbiMedVia a fund
196 portfolio companies: Cookiedatabase.org, ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., Z-Alpha Therapeutics and 193 more
Report a mistake

News

News RTTNews 2 months ago
Disc Medicine Reports Positive Phase 2 RESTORE-PV Data For DISC-3405 In Polycythemia Vera
Disc Medicine, Inc. (IRON), a clinical-stage biopharmaceutical company, presented positive initial results from the RESTORE-PV Phase 2 trial of DISC-3405 in patients with polycythemia vera (PV) at the 2026 Society of Haematology/Oncology (SOHO) annual mee
Read more
Report
News The Motley Fool 7 months ago
Disc Medicine Insider Sells $380K in Stock Amid 70% One-Year Surge
Disc Medicine advances therapies for serious blood disorders; a key insider recently trimmed their stake amid strong one-year share gains.
Read more
Report
News The Motley Fool 8 months ago
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection
This clinical-stage biopharmaceutical company recently had one of its treatments rejected for FDA approval. Now the company is cutting its workforce.
Read more
Report
News seekingalpha.com 10 months ago
Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers Read more
Report
News seekingalpha.com 1 year ago
Disc Medicine Announces Positive Pre-NDA Meeting and Confirms Plans to Submit NDA for Bitopertin in Erythropoietic Protoporphyria (EPP) in October 2025 Read more
Report
News Nasdaq 1 year ago
Disc Medicine Highlights Positive Clinical Data for Bitopertin, DISC-0974, and DISC-3405 at EHA 2025; Management to Host Corporate Update Call
Disc Medicine announces positive updates on bitopertin, DISC-0974, and DISC-3405, with plans for upcoming clinical trials and data presentations.
Read more
Report

Offices

Where the company hires and what each office is for
Cities
4
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Watertown United States
HQ
New York United States
Regional office
New York
careers board
Watertown United States
Regional office
Massachusetts
321 Arsenal Street, Suite 101, Watertown, MA, US
careers board, company site
Carolina United States
Regional office
South Carolina
careers board